Laser Photonics Announces Third Quarter 2024 Results

Rhea-AI Summary

Laser Photonics (NASDAQ: LASE) reported Q3 2024 results showing revenue of $0.8 million, down from $1.3 million in Q3 2023, with a net loss of $1.6 million compared to $0.9 million loss year-over-year. The company secured notable deals with Acuren, U.S. Navy, and expanded into Asia-Pacific through Brokk partnership. The company recently acquired Control Micro Systems (CMS), expanding into healthcare and pharmaceutical industries with over $2 million in unbilled contracted revenue. LPC is developing new products including the Laser Shield Anti-Drone System and Next-Gen CleanTech Robotic Cell.

Positive

• Acquisition of CMS expands business into healthcare and pharmaceutical sectors
• CMS brings $2 million in unbilled contracted revenue
• Secured new contracts with Acuren and U.S. Navy
• Expanded partnership with Brokk into Asia-Pacific region

Negative

• Revenue decreased 38.5% to $0.8M from $1.3M YoY
• Net loss increased to $1.6M from $0.9M YoY
• Operating loss widened to $1.7M from $0.9M YoY
• Loss per share increased to $0.13 from $0.11 YoY

Insights

Financial Analyst

The Q3 results reveal concerning financial trends, with revenue declining 38.5% year-over-year to $0.8 million from $1.3 million. The operating loss widened significantly to $1.7 million from $0.9 million, primarily due to increased investments in HR, sales and administrative functions. The acquisition of CMS brings potential diversification benefits and $2 million in unbilled contracted revenue, but integration costs may further pressure margins in the near term.

The expanded partnerships and new customer wins, particularly in defense and industrial sectors, show promise for future growth. However, the current cash burn rate and widening losses need careful monitoring. The shift towards defense technology with LSAD and pharmaceutical applications through CMS could provide new revenue streams, but commercialization timelines and execution risks remain significant concerns.

Tech Industry Analyst

The strategic expansion into anti-drone systems (LSAD) and pharmaceutical laser applications through the CMS acquisition represents a significant pivot from the core industrial cleaning business. The move into controlled-release drug delivery systems and anti-counterfeiting solutions opens up high-margin opportunities in the pharmaceutical sector. The diversification could help stabilize revenue streams and reduce dependence on cyclical industrial markets.

The expanded partnership with Brokk in the Asia-Pacific region and continued penetration into defense contracts with the U.S. Navy demonstrate market validation. However, the company's ability to execute across multiple technology verticals while managing increased operational costs will be important for long-term success.

ORLANDO, Fla.--(BUSINESS WIRE)-- Laser Photonics Corporation (NASDAQ: LASE), (“LPC”), a leading global developer of CleanTech laser systems for laser cleaning and other material applications, today announced results for its third quarter ended September 30, 2024.

Wayne Tupuola, CEO of Laser Photonics, commented on the third quarter:

“Looking at the quarter, we navigated a challenging period marked by increased investment in HR, Sales, and administrative functions—strategic moves that, while impacting our short-term performance, are essential for our future growth. We also secured several key deals, such as a sale of our CleanTech Industrial Roughening Laser 3050 to Acuren, another sale to the U.S. Navy, and an expansion with Brokk into the Asia-Pacific region. Each of these highlights our ongoing commitment to driving growth and value across strategic verticals.”

“Looking to our future, we're excited about the advancement of our innovative product concepts, including the Laser Shield Anti-Drone System (LSAD) and the Next-Gen CleanTech Robotic Cell, both poised to play critical roles in defense and industrial markets.”

Control Micro Systems (CMS) Acquisition

Tupuola continued, “I’m also thrilled to share details about our recent acquisition of CMS, which was finalized shortly after the third quarter. This acquisition represents a transformative opportunity for Laser Photonics by extending our footprint into the healthcare and pharmaceutical industries, particularly in controlled-release drug delivery and counterproofing pills, while also bringing synergies to our industrial markets. CMS specializes in custom precision laser systems, including laser drilling for controlled-release pharmaceuticals and anti-counterfeiting solutions, aligning perfectly with our vision to innovate in critical, high-growth sectors.

“The CMS acquisition diversifies our portfolio, enhancing our resilience against economic cycles and providing stability to our CleanTech revenue stream. CMS already serves some of the world’s largest pharmaceutical companies, giving us a platform to strengthen relationships with industry leaders and expand our client base. By leveraging LPC’s sales and marketing capabilities, we see significant potential to unlock value in CMS's offerings, supported by over $2 million in unbilled contracted revenue.”

Financial Highlights: (Q324 vs. Q323)

• Revenue: $0.8 million compared to $1.3 million;
• Gross Profit: $0.6 million compared to $1.0 million;
• Operating Loss: ($1.7) million compared to ($0.9) million;
• Net Loss: ($1.6) million from ($0.9) million;
• Loss per Share: ($0.13) compared to ($0.11).

Third Quarter Business Highlights

Announced CleanTech Customer Orders:

• Acuren - a leader in nondestructive testing services, selected LPC’s CleanTech laser systems to support critical inspection and maintenance processes;
• Semiconductor and Solar - A leading poly-silicon manufacturer is using CleanTech to enhance its manufacturing process;
• Oil & Gas: A global company in the oil and gas sector.

Announced DefenseTech Customer Orders:

• U.S. Navy - The Pearl Harbor Naval Shipyard and Intermediate Maintenance Facility integrated LPC’s DefenseTech laser system for the removal of corrosion from naval vessels.

Partnerships:

• Expanded partnership with Brokk to its Australian subsidiary to bring laser cleaning and cutting technology to the mining, tunneling, construction, metal processing, and military ecosystems in Australia, New Zealand and throughout the Asia-Pacific region.

Products:

• Released concept video for Laser Shield Anti-Drone System (LSAD) prototype at LPC's testing facility. The LSAD is a cutting-edge solution in development for the deterrence of unauthorized drone activity;
• Released concept for Next Gen Robotic Clean Cell.

About Laser Photonics Corporation

Laser Photonics is a vertically-integrated manufacturer and R&D Center of Excellence for industrial laser technologies and systems. LPC seeks to disrupt the $46 billion, centuries-old sand and abrasives blasting markets, focusing on surface cleaning, rust removal, corrosion control, de-painting and other laser-based industrial applications. LPC's new generation of leading-edge laser blasting technologies and equipment also addresses the numerous health, safety, environmental, and regulatory issues associated with the old methods. As a result, LPC has quickly gained a reputation as an industry leader for industrial laser systems with a brand that stands for quality, technology and product innovation. Currently, world-renowned and Fortune 1000 manufacturers in the aerospace, automotive, defense, energy, industrial, maritime, space exploration and shipbuilding industries are using LPC's "unique-to-industry" systems. For more information, visit www.laserphotonics.com.

Cautionary Note Concerning Forward-Looking Statements

This press release contains "forward-looking statements" (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended), including statements regarding the Company's plans, prospects, potential results and use of proceeds. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption "Risk Factors" in the Registration Statement. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.

CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except par value data)
(unaudited)
			As of September 30, 2024 (Unaudited)				As of December 31, 2023 (Restated)
Current Assets:
Cash and Cash Equivalents		$	2,121,760			$	6,201,137
Accounts Receivable, Net			725,780				816,364
Account Receivable (related parties)			47,515
Inventory			1,830,725				2,237,455
Other Assets			357,166				39,190
Total Current Assets			5,082,946				9,294,146
Property, Plant, & Equipment, Net			1,258,488				952,811
Intangible Assets, Net			4,026,820				4,279,987
Operating Lease Right-of-Use Asset			252,558				597,143
Total Assets		$	10,620,812			$	15,124,087
Liabilities & Stockholders’ Equity
Current Liabilities:
Accounts Payable		$	533,938			$	223,040
Deferred Revenue			116,564				213,114
Current Portion of Operating Lease			206,212				434,152
Accrued Expenses			30,083				161,538
Total Current Liabilities			886,796				1,031,844
Long Term Liabilities:
Lease liability - less current			46,346				162,991
Total Long Term Liabilities			46,346				162,991
Total Liabilities			933,143				1,194,835
Stockholders’ Equity:
Preferred stock Par value $0.001: 10,000,000 shares authorized. 0 Issued: shares were outstanding as of June 30, 2024 and December 31, 2023			-				-
Common Stock Par Value $0.001: 100,000,000 shares authorized; 12,270,427 and 9,253,419 issued, 12,245,490 and 9,228,482 outstanding as of June 30, 2024, and December 31, 2023			13,832				9,253
Additional Paid in Capital			18,039,795				19,180,725
Retained Earnings (Deficit)			(8,340,719)				(5,235,486)
Treasury Stock			(25,240)				(25,240)
Total Stockholders’ Equity			9,687,669				13,929,252
Total Liabilities & Stockholders’ Equity		$	10,620,812			$	15,124,087

STATEMENTS OF PROFIT AND LOSS
(in thousands, except per share data)
(unaudited)
		Three Months Ended					Nine Months Ended
		September 30, 2024 (Unaudited)		September 30, 2023 (Restated)			September 30, 2024 (Unaudited)		September 30, 2023 (Restated)
Net Sales	$	716,697	$	1,303,205		$	2,083,123	$	2,944,837
Cost of Sales		107,277		333,325			772,481		887,086
Gross Profit		609,420		969,880			1,310,642		2,057,751
Operating Expenses:
Sales & Marketing		554,667		677,026			957,558		1,462,868
General & Administrative		1,053,124		608,647			1,845,166		1,936,521
Depreciation & Amortization		238,617		152,210			652,657		336,294
Payroll Expenses		406,107		347,461			853,264		993,572
Research and Development Cost		62,802		75,431			170,725		155,889
Total Operating Expenses		2,315,316		1,860,774			4,479,370		4,885,144
Operating Income (Loss)		(1,705,896)		(890,894)			(3,168,728)		(2,827,393)
Other Income (Expenses):
Total Other Income (Loss)		80,629		(4,215)			80,666		(4,215)
Income (Loss) Before Tax		(1,625,267)		(895,109)			(3,088,062)		(2,831,608)
Tax Provision		-		-			-		-
Net Income (Loss)	$	(1,625,267)	$	(895,109)		$	(3,088,062)	$	(2,831,608)
Deemed Dividend from Software Acquisition		0		0			(6,615,000)		0
Net Comprehensive loss attributed to Common Shareholders		(1,625,267)		(895,109)			(9,703,062)		(2,831,608)
Earning (Loss) per Share:
Basic and Diluted	$	(0.13)	$	(0.11)		$	(0.28)	$	(0.35)
Loss per share (attributable to common shareholders)		(0.13)		(0.11)			(0.89)		(0.35)
Weighted Average of Shares Outstanding		12,671,166		8,253,417			10,847,009		8,107,584

Statement of Cash Flows
(in thousands)
(unaudited)
		Nine Months Ended
		September 30, 2024 (Restated)				September 30, 2023 (Restated)
OPERATING ACTIVITIES
Net Loss		$	(3,105,233)			$	(2,831,608)
Adjustments to Reconcile Net Loss to Net Cash Flow from Operating Activities:
Bad Debt			208,351
Shares issued for compensation			33,336				-
Distribution to affiliate			(3,822,037)
Depreciation & Amortization			669,828				336,294
Change in Operating Assets & Liabilities:
Accounts Receivable			(165,282)				(36,083)
Inventory			(26,979)				(640,180)
Prepaids & Other Current Assets			(15,976)				5,591
Accounts Payable			311,873				30,140
Accrued Expenses			(132,431)				(338,605)
Deposits			(302,000)
Deferred Revenue			(96,549)				-
Net Cash Used in Operating Activities			(6,443,099)				(3,474,451)
INVESTING ACTIVITIES
Purchase of Property, Plant an Equipment			(57,550)				(124,833)
Purchase of Research & Development Equipment			(5,295)				-
Vehicles							(144,096)
Licenses & Patents							(2,875)
Purchase of Operational Software & Website			-				(34,069)
Invest in Leasehold Improvements			(225,783)				(19,707)
Net Cash Used in Investing Activities			(288,628)				(325,580)
FINANCING ACTIVITIES
Common stock .01 x 100,000,000			(92,533)
Common stock .001 x 100,000,000			13,832
Additional Paid in Capital			2,731,051				(71,250)
Net Cash Used in Financing Activities			2,652,350				(71,250)
Net Cash Flow for Period			(4,079,377)				(3,871,281)
Cash and Cash Equivalents - Beginning of Period			6,201,137				12,181,799
Cash and Cash Equivalents- End of Period		$	2,121,760			$	8,310,518
NON-CASH INVESTING AND FINANCING ACTIVITIES
Shares issued on conversion of debt			-				-
Share issued for purchase of license			6,615,000				-
Common Stock to be issued for cashless exercise of warrants			62

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20241114737203/en/

Investor Relations Contact:

Brian Siegel, IRC, MBA

Senior Managing Director

Hayden IR

(346) 396-8696

laser@haydenir.com

Source: Laser Photonics Corporation

FAQ

What was Laser Photonics (LASE) revenue in Q3 2024?

Laser Photonics reported revenue of $0.8 million in Q3 2024, compared to $1.3 million in Q3 2023.

How much unbilled contracted revenue does the CMS acquisition bring to LASE?

The CMS acquisition brings over $2 million in unbilled contracted revenue to Laser Photonics.

What was LASE's net loss per share in Q3 2024?

Laser Photonics reported a loss per share of $0.13 in Q3 2024, compared to $0.11 in Q3 2023.

What new markets did LASE expand into through the CMS acquisition?

Through the CMS acquisition, LASE expanded into healthcare and pharmaceutical industries, particularly in controlled-release drug delivery and counterproofing pills.